Sigyn Therapeutics, Inc. cotiza a 0.04 USD y tiene una capitalización bursátil de $194380. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, inclu…
| Métrica | SIGY | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -1562.9% | -32.0% | -1530.9% |
| Current Ratio | 0.00 | 2.84 | -2.84 |
| Debt / Equity | -0.45 | 0.28 | -0.73 |